3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase NA
1
Phase 2/3
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
2
Sarcoma, Ewing
1
Patient Compliance
1
Pathologic Complete Response
1
Osteosarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangiosarcoma
1
Chondrosarcoma
1
Bone Neoplasms
1
Interventions
Radiotherapy, Intensity-Modulated
2
Magnetic Resonance Spectroscopy
2
regorafenib
1
delta 24-sterol reductase
1
Vinorelbine
1
Standard of Care
1
Specimen Handling
1
Resistance Training
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Radiation
1
Proton Therapy
1
Physical Therapy Modalities
1
Liquid Biopsy
1
IVA protocol
1
Electroacupuncture
1
Drug Therapy
1
Doxorubicin
1
Cyclophosphamide
1
Congresses as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Sarcoma, Ewing
×
regorafenib
×
Clear all
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled